J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
The Journal of Clinical Pharmacology and New Drugs, 1970; 10:203-206
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Claghorn, J.
Right arrow Articles by Schoolar, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Claghorn, J.
Right arrow Articles by Schoolar, J. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The Behavioral Pharmacology of Oxypertine

James Claghorn M.D.1 and Joseph C. Schoolar Ph.D., M.D.1

1 Texas Research Institute of Mental Sciences, Baylor University College of Medicine, and The University of Texas Graduate School of Biomedical Sciences, Houston, Tex.

Oxypertine is an indole-based compound with antipsychotic properties which other studies have indicated might be especially useful in aiding the psychotherapeutic treatment of withdrawn schizophrenics. This study compared the effects of oxypertine and chlorpromazine in 40 schizophrenic males using clinical evaluation, NOSIE, and BPRS scales. Effective dosage for oxypertine was established at approximately 300 mg daily and there were fewer side effects reported for the oxypertine group than for the chlorpromazine group. Chlorpromazine was effective in more BPRS items than oxypertine and is a more sedative drug.

Note:

I wish to express my appreciation to Mrs. Joyce McReynolds and Mrs. Gerri Blauser for their assistance in this study.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1970 by the American College of Clinical Pharmacology